Cargando…

Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()

BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemirovsky, Anna, Ilan, Karny, Lerner, Livnat, Cohen-Lavi, Liel, Schwartz, Doron, Goren, Ganit, Sergienko, Ruslan, Greenberg, Dan, Slonim-Nevo, Vered, Sarid, Orly, Friger, Michael, Regev, Shirley, Odes, Shmuel, Hertz, Tomer, Monsonego, Alon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728050/
https://www.ncbi.nlm.nih.gov/pubmed/35024638
http://dx.doi.org/10.1016/j.bbih.2021.100407
_version_ 1784626647485382656
author Nemirovsky, Anna
Ilan, Karny
Lerner, Livnat
Cohen-Lavi, Liel
Schwartz, Doron
Goren, Ganit
Sergienko, Ruslan
Greenberg, Dan
Slonim-Nevo, Vered
Sarid, Orly
Friger, Michael
Regev, Shirley
Odes, Shmuel
Hertz, Tomer
Monsonego, Alon
author_facet Nemirovsky, Anna
Ilan, Karny
Lerner, Livnat
Cohen-Lavi, Liel
Schwartz, Doron
Goren, Ganit
Sergienko, Ruslan
Greenberg, Dan
Slonim-Nevo, Vered
Sarid, Orly
Friger, Michael
Regev, Shirley
Odes, Shmuel
Hertz, Tomer
Monsonego, Alon
author_sort Nemirovsky, Anna
collection PubMed
description BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their inflammatory state, and whether a 3-month trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) impacts their inflammatory process. METHODS: Circulating inflammatory markers and a wide range of psychological parameters related to stress and well-being were measured in CD patients before and after COBMINDEX. Inflammatory markers in CD patients were also compared to age- and sex-matched healthy controls (HCs). RESULTS: CD patients exhibited increased peripheral low-grade inflammation compared with HCs, demonstrated by interconnected inflammatory modules represented by IL-6, TNFα, IL-17, MCP-1 and IL-18. Notably, higher IL-18 levels correlated with higher score of stress and a lower score of wellbeing in CD patients. COBMINDEX was accompanied by changes in inflammatory markers that coincided with changes in cortisol: changes in serum levels of cortisol correlated positively with those of IL-10 and IFNα and negatively with those of MCP-1. Furthermore, inflammatory markers of CD patients at baseline predicted COBMINDEX efficacy, as higher levels of distinct cytokines and cortisol at baseline, correlated negatively with changes in disease activity (by Harvey-Bradshaw Index) and psychological distress (global severity index measure) following COBMINDEX. CONCLUSION: CD patients have a characteristic immunological profile that correlates with psychological stress, and disease severity. We suggest that COBMINDEX induces stress resilience in CD patients, which impacts their well-being, and their disease-associated inflammatory process.
format Online
Article
Text
id pubmed-8728050
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87280502022-01-11 Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() Nemirovsky, Anna Ilan, Karny Lerner, Livnat Cohen-Lavi, Liel Schwartz, Doron Goren, Ganit Sergienko, Ruslan Greenberg, Dan Slonim-Nevo, Vered Sarid, Orly Friger, Michael Regev, Shirley Odes, Shmuel Hertz, Tomer Monsonego, Alon Brain Behav Immun Health Full Length Article BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their inflammatory state, and whether a 3-month trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) impacts their inflammatory process. METHODS: Circulating inflammatory markers and a wide range of psychological parameters related to stress and well-being were measured in CD patients before and after COBMINDEX. Inflammatory markers in CD patients were also compared to age- and sex-matched healthy controls (HCs). RESULTS: CD patients exhibited increased peripheral low-grade inflammation compared with HCs, demonstrated by interconnected inflammatory modules represented by IL-6, TNFα, IL-17, MCP-1 and IL-18. Notably, higher IL-18 levels correlated with higher score of stress and a lower score of wellbeing in CD patients. COBMINDEX was accompanied by changes in inflammatory markers that coincided with changes in cortisol: changes in serum levels of cortisol correlated positively with those of IL-10 and IFNα and negatively with those of MCP-1. Furthermore, inflammatory markers of CD patients at baseline predicted COBMINDEX efficacy, as higher levels of distinct cytokines and cortisol at baseline, correlated negatively with changes in disease activity (by Harvey-Bradshaw Index) and psychological distress (global severity index measure) following COBMINDEX. CONCLUSION: CD patients have a characteristic immunological profile that correlates with psychological stress, and disease severity. We suggest that COBMINDEX induces stress resilience in CD patients, which impacts their well-being, and their disease-associated inflammatory process. Elsevier 2021-12-23 /pmc/articles/PMC8728050/ /pubmed/35024638 http://dx.doi.org/10.1016/j.bbih.2021.100407 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Nemirovsky, Anna
Ilan, Karny
Lerner, Livnat
Cohen-Lavi, Liel
Schwartz, Doron
Goren, Ganit
Sergienko, Ruslan
Greenberg, Dan
Slonim-Nevo, Vered
Sarid, Orly
Friger, Michael
Regev, Shirley
Odes, Shmuel
Hertz, Tomer
Monsonego, Alon
Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title_full Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title_fullStr Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title_full_unstemmed Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title_short Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
title_sort brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: observations from a randomized controlled trial in patients with crohn's disease()
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728050/
https://www.ncbi.nlm.nih.gov/pubmed/35024638
http://dx.doi.org/10.1016/j.bbih.2021.100407
work_keys_str_mv AT nemirovskyanna brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT ilankarny brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT lernerlivnat brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT cohenlaviliel brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT schwartzdoron brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT gorenganit brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT sergienkoruslan brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT greenbergdan brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT slonimnevovered brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT saridorly brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT frigermichael brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT regevshirley brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT odesshmuel brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT hertztomer brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT monsonegoalon brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease
AT brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease